David Toung Analyst PerformanceSenior Analyst at ArgusDavid Toung is a stock analyst at Argus focused in the medical sector, covering 21 publicly traded companies. Over the past year, David Toung has issued 7 stock ratings, including buy and hold recommendations. While full access to David Toung's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Toung's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings36 Last 10 YearsBuy Recommendations85.29% 29 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution34RatingsDistribution of strong buy, buy, hold, and sell ratings by David Toung.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.3%29 ratings Hold14.7%5 ratings Sell0.0%0 ratingsOut of 34 total stock ratings issued by David Toung at Argus, the majority (85.3%) have been Buy recommendations, followed by 14.7% Hold.Best & Worst CallsBest Call000.0%MCKNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CRLAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE76.2% of companies on NYSE16 companiesNASDAQ23.8% of companies on NASDAQ5 companiesDavid Toung, an analyst at Argus, currently covers 21 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical20 companies95.2%Computer and Technology1 company4.8%David Toung of Argus specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED PRODUCTS5 companies23.8%MEDICAL SERVICES3 companies14.3%MED INSTRUMENTS3 companies14.3%MED - BIOMED/GENE3 companies14.3%MED - HMO2 companies9.5%MED/DENTAL - SUPP2 companies9.5%ELEC COMP - SEMIC1 company4.8%LARGE CAP PHARMA1 company4.8%PHARMACEUTICAL PREPARATIONS1 company4.8% David Toung's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDTMedtronic8/26/2025Boost Price Target$92.05$115.00Buy$0.0000.00% ROIELVElevance Health7/21/2025Reiterated Rating$276.87Hold$0.0000.00% ROIGFSGlobalFoundries7/1/2025Initiated Coverage$38.20$52.00Buy$0.0000.00% ROITMOThermo Fisher Scientific4/29/2025Lower Price Target$426.24$470.00Buy$0.0000.00% ROIUNHUnitedHealth Group4/21/2025Downgrade$456.10Hold$0.0000.00% ROIIARTIntegra LifeSciences3/31/2025Upgrade$21.69Buy$0.0000.00% ROISYKStryker2/3/2025Set Price Target$382.59$450.00$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
